Kestra Private Wealth Services’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
VCM
VPM
EIG
Kestra Private Wealth Services's DGX Position: Q1 2026 in Review
Kestra Private Wealth Services increased its Quest Diagnostics (DGX) stake by 101% in Q1 2026, buying an estimated $570K and bringing the position to 5,848 shares worth $1.15M. The position accounts for 0.01% of the portfolio, ranked #765.
Kestra Private Wealth Services first reported a position in DGX in Q2 2021 and has held it in 11 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Kestra Private Wealth Services held 5,848 shares of Quest Diagnostics worth $1.15M as of Q1 2026.
- Kestra Private Wealth Services bought 2,935 Quest Diagnostics shares in Q1 2026, an estimated $570K.
- Quest Diagnostics made up 0.01% of Kestra Private Wealth Services's portfolio in Q1 2026, its #765 holding.
- Kestra Private Wealth Services first reported a position in Quest Diagnostics in Q2 2021 and has held it in 11 quarters since.
- 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Kestra Private Wealth Services's 13F filing for Q1 2026, filed 20 Apr 2026.